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Strongmen are characterised by large mass 
they use to perform feats of strength, the 
effect this large mass has on the athlete’s 
health are unknown. The aim of this study 
was to: characterise a group of strongmen 
and to compare observed values with 
established parameters for good health. 
We measured: resting metabolic rate, 
body composition, skinfolds, lipid profiles, 
fasted glucose, blood pressure, power 
output, and grip strength in 6 competitive 
strongmen over 6 months. Blood pressure 
varied with 3 of the strongmen recording 
hypertensive values. Fasted blood glucose 
levels aligned with values for healthy 
adults, cholesterol/lipid profiles variable 
with the suggestion that values are 
generally poorer in strongmen than in 
healthy adults. The large body mass of the 
strongmen corresponded with a large 
amount of adipose tissue, which may incur 
risk for non-communicable disease. 
Furthermore, the risk of disease may be 
further compounded by anabolic steroid 
use. Dietary considerations are made for 
protecting cardiovascular health and the 
potential for 'healthy' weight gain. To our 
knowledge this is the first such nested 
cohort study in the area of strongmen 
competitors.  Larger studies are needed to 
confirm and further elucidate this data. 
Considerations for protecting the health of 
strongman competition is made.  
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The first “World’s Strongest Man” (WSM) 
competition took place in 1977 involving 
strength and power athletes from different 
sports including: American football, 
Olympic weightlifting, bodybuilding, 
powerlifting, wrestling and track and field. 
Since the original WSM competition, 
strongman has become a sport in its own 
right; competitors train specifically to 
develop strength and muscular endurance 
to complete 5 to 6 events in the fastest 
time possible. Events are usually based 
upon mythical feats of strength combined 
with conventional barbell tests, examples 
include: the ‘farmers' walk’ where 
competitors carry heavy objects (often 
anvils), over a set distance and the “Atlas 
Stones” where athletes lift 5 progressively 
heavier stone boulders onto platforms (1). 
Strongmen are characterised as being very 
tall and heavy, for example, WSM 
competitor Brian Shaw is 2.03 m tall, 
weighs 200kg and has a BMI of 48.5 kg/m2.   
The large body mass of elite strongmen 
and their astounding strength perhaps 
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gives credence to the conventional 
strongman wisdom that “mass moves 
mass”. However, this large body mass 
increases an individual’s body mass index 
(BMI), and where excess mass is fat mass 
(FM), may represent a significant risk to 
health. Obesity, classified as a body mass 
index (BMI) greater than 29.9 kg/m2, or a 
body fat percentage (BF%) greater than 25, 
may lead to insulin resistance, 
dyslipidaemia and arterial hypertension 
increasing the risk of cardiovascular 
disease (CVD) and type 2 diabetes mellitus 
(T2DM) (2,3). Moreover, retrospective 
cohorts indicate that life expectancy is 
reduced between 8 to 10 years when BMI 
is greater than 40 kg/m2 (4). Despite this 
high BMI, strongmen regularly engage in 
exercise and have high levels of fat free 
mass (FFM) which may offer some 
protection against CVD and T2DM. There is 
however a paucity of research on 
strongman populations to determine the 
existing health status of these athletes. 
The previous research conducted on 
strongman has focussed, on the physiology 
related to strongman training (4), 
prevalence of injury (5) and ‘tapering’ 
training prior to competition (6).  
A Study of offensive linesman from the 
National Football League (NFL) however is 
useful for making comparisons. For 
example, the average bodyweight of 
offensive linesmen reported in literature is 
140 - 143 kg, BMI 37.8 kg/m2 (7,8). These 
athletes are similar in stature to strongmen 
competitors (9). Of the 109 offensive 
linesmen recruited by Tucker et al. (8) 
nearly all (n - 104) had a waist 
circumference (WC) over the 102 cm 
World Health Organisation (WHO) CVD 
high risk cut off n - 26 were hypertensive, 
n - 70 pre-hypertensive, and n - 25 had a 
total cholesterol (TC) greater than 200 
mg/dL. Interestingly, despite their high 
BMI’s just over half (n - 61) had a body fat 
% over 25, only n - 7 a waist to hip ratio 
(WHR) over 1.0, and all players had normal 
fasting blood glucose, suggesting a 
probable protective effect associated with 
lean body mass (LBM) and exercise (8). To 
confirm this 'protection' the authors 
concluded that CVD risk for the linesmen 
was similar to that of the slimmer general 
population, and that their physical activity 
output seemed to mitigate the effect of 
their large size. Post retirement however, 
the NFL linesman appear to be susceptible 
to developing metabolic syndrome (10).  
Finally, competitive strongman does not 
adhere to the World Anti-Doping Agency 
Code, and like other non-Olympic sports, 
the use of androgenic anabolic steroids 
(AAS) and other prohibited substances is 
thought to be widespread. Despite a lack 
of documented accounts of steroid use by 
strongmen in the scientific literature, the 
lay media have speculated several high-
profile deaths in strongmen were caused 
by AAS use (11-15) and supraphysiological 
AAS use is generally associated with 
myocardial dysfunction (16). In the present 
investigation anthropometric 
measurements, cardiometabolic 
measurements and performance outcome 
markers are measured in six strongmen 




Presentation of the athletes 
 
The present observation was performed 
on 6 active male strongmen. One of the 
athletes competing international and had 
previously placed in the top 3 of the UKs 
Strongest Man and World Team 
Strongman Championships. Another 
competed as a master’s strongman and 
was an international level IPF powerlifter, 
the remaining participants had all 
competed at national or regional 
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strongman level. Participants visited the 
laboratory on three occasions separated 
by 12 weeks (baseline, 12 wks, and 24 
wks). At each visit the participant’s 
metabolic health, exercise performance, 
anthropometric characteristics and dietary 
intake was assessed. Three of the six 
strongmen attended all three laboratory 
visits, two visited the laboratory on two 
occasions and one participant visited the 
laboratory only once. Four of the 
strongmen reported using AAS throughout 
the observation. All participants provided 
written informed consent before 
participation, and provided approval for 
publication of the data. This research 
project was approved by the university 
ethical review board. 
 
Indirect calorimetry and RMR prediction 
equations 
 
Resting metabolic rate (RMR) was 
established using the conventions for good 
practice (17). Participants reported to the 
laboratory between 08:00 and 10:00 a.m 
following an overnight fast from 10 pm. On 
the morning of testing, participants were 
asked to refrain from physical activity 
(cycling, brisk walking, taking the stairs). 
Participants were asked to abstain from 
alcohol 24 h preceding each visit and from 
caffeine on the morning of their visit. 
Participants were also asked to consume 
500 ml of water on the morning of the trial 
to encourage hydration. Participants 
rested in the supine position for 20 mins, 
followed by 10 mins wearing a facemask 
for the measurement of RMR (AS 
Instruments, Oxford, United Kingdom). 
RMR was captured by breath-by-breath 
measurements of oxygen consumption 
(V̇O2) and carbon dioxide (V̇CO2) collected 
via Douglas bag and analysed immediately 
for volume of O2 and CO2 fractions using 
an electronic gas analyser (GIR250, MTL, 
Luton, United Kingdom). The total volume 
of gas expired was then measured 
including the fraction extracted for the gas 
analyser. The gas analyser was calibrated 
prior to use by testing a known gas 
concentrations (4 % CO2; 16 % O2, 100 % 
N2, MTL, Luton, United Kingdom). Two 
five-minute gas samples were collected via 
Douglas bags and analysed. If a respiratory 
coefficient (RQ) of < 0.7 or > than 1.0 was 
recorded this was considered a protocol 
violation. A Coefficient of variation (CV) of 
< 10 % was considered acceptable for V̇O2 
and V̇CO2. Environmental conditions 
during testing were: humidity 27.9 ± 7.2 %; 
temperature 22.1 ± 2.6 °C.  
 
Two prediction equations were used to 
estimate BMR: Schofield (18) and 
Cunningham (19). The Schofeild (18) 
estimates BMR based on body mass, age 
and sex, and is the preferred method for 
estimating BMR by WHO (20). The 
Cunningham (19) equation estimates BMR 
based on the FFM, estimated using 
bioelectrical impedance (BIA). RMR was 
then compared to prediction estimates 
and the difference calculated. 
 
Body composition/anthropometry and 
ultrasound 
 
Height and weight were measured using a 
stadiometer (Holtain, Crymych, United 
Kingdom) and a Tanita multi-frequency BIA 
analyser (InBody 720, Biospace, 
Urbandale, Iowa, USA). The Tanita was also 
used to assess fat mass (FM), fat free mass 
(FFM) and total body water. BMI and the 
fat free mass index (FFMI) were calculated 
as kg/m2 and FFM kg/m2.  Ultrasound 
(Bodymetrix, Professional Ultrasound, 
Cartwright fitness, Chester, UK) was used 
to perform a 7-site skin fold assessment. 
The sum of these skinfolds was used to 
calculate a BF% (21). Briefly, a thin layer of 
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ultrasound gel was applied to the wand 
head and then wiped across the skin at the 
skin fold site. The ultrasound was then held 
perpendicular to the point of skin contact 
at each of the observable sites: pectoralis 
minor, subscapular, axilla, triceps, 
suprailliac, rectus abdominis, and 
quadriceps. Differentiation between tissue 
interfaces (muscle mass, body fat and 
bone) was determined based on the 
thickness of tissues and length of time for 
ultrasonic waves to pass through and 
reflect back to the sound head of the 
transducer. Local averaging of each signal 
at each site was performed. Ultrasound 
signals were interpreted using the 
Bodymetrix ultrasound analysis software 
(IntelaMetrix, Brentwood, California, 
United States).  
 
Blood pressure and resting heart rate 
 
Blood pressure and heart rate were 
measured in a supine position following 
RMR measurements. Resting heart rate, 
and blood pressure, was determined using 
a digital blood pressure monitor (UA-787 
Plus, A & D Instruments Ltd, Oxfordshire, 
UK). Cuff size (22-32 cm or 32-45 cm) was 
selected on a case-by-case basis. 
Measurements were made in triplicate and 




A single-use lancing device (Accu-chek 
Softclix Pro, Roche Diagnostics Ltd, West 
Sussex, UK) was used to obtain capillary 
blood samples. To determine TC, whole 
blood triglycerides (TAG) and creatine 
kinase (CK), two 30-μL samples were 
collected in Microsafe collection and 
dispensing tubes (Inverness Medical, 
Cheshire, UK) and applied immediately to: 
Reflotron TC test strips (measurement 
range, 2.59 - 12.9 mmol/L); Reflotron TAG 
test strips (measurement range, 0.80 - 6.86 
mmol/L); and Reflotron CK test strips 
(measurement range, 25 – 1900 U/I) (all 
Inverness Medical, Cheshire, UK). For HDL 
whole blood was collected in 300 μL EDTA 
dipotassium salt–coated centrifuge tubes 
(Microvette CB 300, 
Hematology/Potassium EDTA; SARSTEDT 
Ltd, Leicestershire, UK), spun at room 
temperature for 2 mins (Centrifuge MC6; 
SARSTEDT Ltd) and 30 µl of plasma applied 
to a Reflotron HDL test strip (measurement 
range, 0.26-2.59 mmol/L). The low-density 
lipoprotein (LDL) fraction was estimated by 
subtracting the sum of total TAG and HDL 
divided by 2.19, from TC. The Reflotron 
Plus (Inverness Medical), a reflectance 
photometer, was then used to analyse 
each sample. Fasted blood glucose was 
measured via a 20 µl whole blood samples 
added to an aliquot containing heparin and 
saline before being read using a Biosen C-
line (EKF diagnostics, Ebendorfer, 
Germany).  
 
Testosterone and C-reactive protein (CRP) 
 
Salivary testosterone, and CRP was 
measured for participants 1, 2, and 3 using 
a commercially available enzyme 
immunoassay (Salimetrics, Carlsbad, 
California, USA). The range of sensitivity 
was 6.1 to 600 pg/ml, and 0.0 to 3000 
pg/ml for testosterone, and CRP 
respectively. Participants expectorated 5 
ml of saliva into a collection tube which 
was centrifuged (10,000 g × 10 mins) 
before the supernatant was removed for 
long term storage (-80 °C). Analysis was 
performed as per manufactures 
instructions and samples were analysed in 
duplicate. The procedure was the same for 
both kits with the exception of the 
antibody enzyme conjugate and enzyme 
coated 96 well plate.   Briefly, standards, 
controls and samples were added to a 96 
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well followed by the antibody enzyme 
conjugate and mixed on a plate rotator at 
500 rpm for 2 h, at room temperature. The 
plate was then washed with a buffer 
containing phosphate and dH2O, before 
the addition of Tetramethylbenzidine 
solution (which produces a light reaction), 
followed by mixing at 500 rpm, for 30 min 
at room temperature. A stop solution 
(Sulfuric acid) was then added and mixed 
at 500 rpm for a further 3 mins at room 
temperature. Samples were then read on a 
plate reader within 5 minutes at 450 nm 
(Synergy HT, BioTek Instruments, Winoski, 
Vermont, USA), and Gen5 microplate 
reader software (BioTek Instruments, 
Winoski, Vermont, USA). 
 
Anaerobic power and hand grip strength  
 
Anaerobic power was measured using a 
Wingate tests on a Velotron cycle (Racer-
Mate, Seattle, WA). Participants pedalled 
at maximum effort, attempting to attain a 
maximum number of pedal revolutions 
against a load equal to 7.5% of their 
bodyweight. The protocol was as follows: 
participants performed a 5 min warm-up at 
a rate equivalent to 50 watts, before 
completing a familiarisation phase. The 
familiarisation involved a 20 s lead in, 
before a 10 second acceleration phase 
which included a countdown, at the end of 
which the load was automatically added to 
the flywheel for 3 s. After this 
familiarisation phase the load was 
removed and participants returned to the 
warm up pace for a further 2 min. The 
protocol was then repeated with the 20 s 
lead in, 10 s second acceleration phase, 
before the load was added and 
participants attempted a maximal effort 
for 20 s with verbal encouragement. The 
peak power output, mean power output, 
and output scaled for bodyweight were all 
obtained from the Velotron software 
(RaceMate One V.4.1.0.6). Hand grip 
strength (HGS) was measured using a Hand 
Grip Dynamometer (Takei, Nigata City, 
Nigata Pref, Japan). Strength was 
measured in both hands, and participants 
adjusted the handle position to suit their 
own preference repeated at each visit. The 
test arm was positioned parallel to the 
floor with the elbow flexed at 180°, the 
participant then performed a maximal 
isometric contraction by squeezing the 
dynamometer while bringing their arm 
parallel to their lower body. Each 
participant performed three maximum 
strength attempts per hand allowing for 30 
s rest between attempts.      
              
Dietary intake 
 
A 24 h dietary recall interview was carried 
out by a registered nutritionist (AC) for all 
participants. Participants documented all 
food items and beverages consumed in the 
previous 24 h, along with weights and/or 
portion sizes. Diets were then analysed 
using dietary analysis software (Nutritics 
Research Edition v5.092, Dublin, Ireland). 
Total energy intake, macronutrient and 
caffeine intake are expressed as (kcal), (g) 
and (mg), and scaled for bodyweight as 
kcal/kg, g/kg and mg/kg of bodyweight 
(BW). Energy intake and protein intake 
from dietary supplements was determined 
based on nutritional information obtained 
from manufacturers websites. Energy 
availability was calculated based on the 
total energy intake, minus the measured 
RMR. Finally, the mean number of food 
items consumed was counted. The 
percentage of the diet made up of specific 
food groups was based on the European 
Food Safety Agency food classification 
system for dietary reporting (22). Any food 
group making up less than 1 % of the 
dietary intake was placed in the 'others' 
category. 
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RESULTS 
 
Participant characteristics and indirect 
calorimetry 
 
The mean age and height of participants 
was 33.5 ± 5.8 yrs and 1.85 ± 0.07 m. 
Individual anthropometric characteristics 
at baseline, 12 and 24 wks are reported in 
table 1. The body mass and BMI of the 
cohort was between 100.7 to 178.7 kg and 
33.1 to 48.0 kg/m2. Measurement of BF% 
by ultrasound were consistently reported 
53-66% lower than the BIA method 
resulting in higher estimates of FFM 
between 4.6 to 19.5 % using the 
ultrasound (table 1). Mean salivary 
testosterone was: baseline, 928 ± 587 
pg/ml; 12 wks, 469 ± 112 pg/ml; 24 wks, 
732 ± 343 pg/ml. Mean CRP concentrations 
were: baseline, 383 ± 259 pg/ml; 12 wks, 
999 ± 557 pg/ml; 24 wks, 126 ± 83 pg/ml. 
RMR, predicted BMR, blood pressure, 
heart rate and metabolic markers (fasting 
blood glucose, blood lipids and CK) are 
reported in table 2. Measured RMR ranged 
between 1179 kcal in the smallest 
participant to 4988 kcal in the largest. BMR 
prediction equations estimated energy 
requirements between 53 to 64 % lower 
and higher than RMR, with no discernible 
pattern trend (table 2). 
 
Dietary intake of strongmen populations 
 
Participant’s 24 h nutrient intake is 
reported in table 3. Macronutrient and 
energy intake ranged from: CHO 213 to 
1183 g, PRO 200 to 464 g, fat 67 to 162 g, 
energy 3014 to 9427 kcal. Participants 
consumed a mean of 15.4 individual food 
items per day. Dairy as full fat yoghurt, 
whey and milk, cereal as oats, fruits and 
vegetables and confectionary were 
popular food items. The contribution each 
food group made to the cohort’s diet is 
presented in figure 1. A sample diet for 
participant 3 is provided as a 
supplementary table (S1). Competitors 
reported consuming between 1 to 4 
dietary supplements throughout the study.  
Whey protein was the most commonly 
consumed supplement, maltodextrin, 
multi ingredient pre-exercise formulas and 
branch chain amino acids were also 
consumed.   
 
Performance metrics of strongmen 
competitors 
 
Results of the Wingate testing and HGS are 
presented in table 4. Power output relative 
to LBM is presented as a supplement (S2). 
Peak power output and anaerobic power 
scaled for BW ranged 979 to 1971 W, and 
6.9 to 12.3 W/kg BW. The mean watts 
achieved over the Wingate and the 
anaerobic capacity scaled for BW was 
between 574 to 1230 W and 4.0 to 9.0 
W/kg BW. HGS in the left hand was 
between 37 and 76 kgf, while strength in 
the right was between 47 and 87 kgf. The 
difference in strength between the left and 
the right reflect more right handed 
dominant participants in the study. 
Wingate performance scaled for LBM 
indicated that the highest power outputs 
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Table 1 Anthropometric Observations of Strongmen Competitors 
 Baseline  12 weeks  24 weeks 
Participant 1 2 3 4 5 6  1 2 3 4 5  1 2 3 
Height (cm) 1.80 1.93 1.91 1.90 1.75 1.82  1.80 1.93 1.91 1.90 1.75  1.8 1.93 1.91 
Weight (kg) 141.9 178.7 140.8 140.9 100.7 129.9  138 172.7 137.8 134.7 101.5  143.1 170.1 133.2 
BMI (kg/m2) 43.8 48.0 38.6 39.0 33.1 39.4  42.6 46.4 37.8 37.3 33.3  44.2 45.7 36.5 
Ʃ 7 Skin Folds (cm) 81.4 108.6 59.7 56.2 84.5 107.3  95.2 103.4 63.3 52.1 77  95.5 98.6 64.5 
Left Bicep Muscle Thickness (mm) 53.2 55.8 55.1 60.1 44.0 40.0  - 58.2 65.1 58.6 46.0  52.7 56.6 52.3 
Right Bicep Muscle Thickness (mm) 52.2 59.0 59.4 57.6 40.6 40.4  - 55.8 60.7 64.8 41.0  53.0 56.9 57.8 
Fat Free Mass: Ultrasound (kg) 113.0 132.8 116.0 119.6 77.9 96.1  106.1 129.4 113.3 116.0 79.9  109.5 128.1 108.7 
Body Fat: Ultrasound (%) 20.3 25.7 17.6 15.1 22.6 26.0  23.1 25.1 17.8 13.9 21.3  23.5 24.7 18.4 
Lean Body Mass: BIA (kg) 91.0 108.5 97.1 101.0 72.4 84.7  86.5 108.8 100.9 98.6 76.1  91.7 107.8 99.2 
Body Fat: BIA (%) 35.9 39.3 31.0 28.3 28.1 34.8  37.3 37.0 26.8 26.8 25.0  35.9 36.6 25.5 
Total Body Water (%) 51.3 46.6 51.4 55.6 52.4 49.7  47.0 50.4 56.9 60.0 56.4  51.3 50.7 57.2 
FFMI: Ultrasound (kg/m2) 34.9 35.6 31.8 33.1 25.6 29.2  32.7 34.7 31.0 32.1 26.2  33.8 34.4 29.8 
FFMI: BIA (kg/m2) 28.1 29.1 26.6 28.0 23.8 25.7  26.7 29.2 27.6 27.3 25.0  28.3 29.0 27.2 
FFMI: Difference Ultrasound to BIA (%) 19.5 18.3 16.4 15.4 7.1 12.0  16.9 15.9 11.0 15.0 4.6  16.3 15.7 8.7 
Waist Circumference (cm) 125.4 138.5 116.0 116.0 105.0 116.0  124.5 136.0 114.5 112 103.5  127.5 138 112 
Hip Circumference (cm) 133.6 141.0 125.5 117.0 110.0 129.0  128.0 139.0 119.0 112.5 111  132.5 137 118.5 
Waist To Hip Ratio 0.94 0.98 0.92 1.0 0.95 0.90  0.97 0.98 0.96 1.00 0.93  0.96 1.01 0.95 
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Table 2. Estimated Energy Requirements and Selected Health Indices of Strongmen Competitor 












 Baseline  12 weeks  24 weeks 
Participant no. 1 2 3 4 5 6  1 2 3 4 5  1 2 3 
Measured RMR (kcal/day) 2403 3719 3414 2330 1179 2416  2386 3559 3785 3337 2524  2326 4988 3375 
Schofield BMR (kcal/day) 2829 3383 2812 2814 2208 2648  2770 3293 2767 2720 2221  2847 3253 2698 
Cunningham BMR (kcal/day)* 2335 2713 2469 2552 1934 2199  2239 2720 2549 2450 2014  2351 2699 2514 
Diff between predictive (Schofield) 
and RMR 
+16% -9% -21% +18% +47% +9%  +14% -7% -37% -22% -13%  +18% -53% -25% 
Diff between predictive 
(Cunningham) and RMR 
-3% -27% -28% +10% +64% -9%  -6% -24% -33% -27% -20%  +1% -46% -26% 
SYS Blood pressure (mmHg) 129 130 141 136 123 127  124 131 121 119 107  126 131 124 
DIA Blood pressure (mmHg) 76 90 100 88 84 86  65 89 65 73 71  74 85 73 
Resting Heart Rate (bpm) 68 82 85 70 65 72  60 79 94 72 64  69 65 59 
Fasting Blood Glucose (mmol/l) 5.2 4.7 4.3 4.2 4.0 4.7  5.8 4.2 4.3 4.2 4.0  3.7 5.4 4.9 
Total Cholesterol (mmol/l) 4.5 9.9 4.0 6.9 4.9 5.4  4.4 5.0 5.0 4.8 4.2  4.3 5.6 3.6 
HDL (mmol/l) 1.4 - - - 1.3 0.6  - 0.7 0.8 0.8 1.0  1.0 0.6 1.0 
LDL (mmol/l) 0.9 - - - 0.7 1.1  - 1.3 1.2 1.0 0.8  1.1 1.5 0.7 
Triglycerides (mmol/l) 1.2 1.4 1.9 1.0 2.0 2.2  1.8 1.4 1.6 1.9 1.5  0.8 1.7 1.1 
Creatine Kinase (U/I) 150 662 52 190 278 30  863 162 52 543 714  86 24 929 
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Table 3. Dietary Intake of Strongmen Over 24 weeks  
 Baseline  12 weeks  24 weeks 
Participant no. 1 2 3 4 5 6  1 2 3 4 5  1 2 3 
Total Intake                 
CHO (g) - 582 1183 528 549 213  276 768 1039 313 510  507 309 989 
Free sugars (g) - 1 309 62 168 46  41 104 273 7 92  107 0.23 300 
Fibre (g) - 32 59 36 19 26  21 65 75 29 25  38.8 6.9 92 
PRO (g) - 464 302 414 297 200  291 428 300 302 310  389 276 349 
Fat (g) - 264 388 233 67 156  83 252 400 162 115  119 75 346 
Saturated Fat (g) - 123 162 112 35 59  20 91 123 71 46  34 36 124 
Energy (kcal) - 6560 9427 5860 3991 3055  3014 7048 9427 3916 4517  4760 3018 8463 
Energy Availability (Kcal) - 2841 6014 3530 2812 639  628 3489 5643 579 1993  2434 -1970 5088 
Caffeine Intake (mg) - 176 466 224 338 0  0 473 468 288 463  276 126 396 
Intake Scaled for BW  1.0 3.3 1.6 3.4 0  0 2.7 3.4 2.1 4.6  1.9 0.7 3.0 
CHO (g/kg BW) - 3.3 8.4 3.7 5.5 1.6  2.0 4.4 7.5 2.3 5.0  3.5 1.8 7.4 
PRO (g/kg BW) - 2.6 2.1 2.9 2.9 1.5  2.1 2.5 2.2 2.2 3.1  2.7 1.6 2.6 
Fat (g/kg BW) - 1.5 2.8 1.7 0.7 1.2  0.6 1.5 2.9 1.2 1.1  0.8 0.4 2.6 
Energy (kcal/kg BW) - 36.7 67.0 41.6 39.6 23.5  21.8 40.8 68.4 29.1 44.5  33.3 17.7 63.5 
Adjusted Caffeine (mg/kg BW) - 1.0 3.3 1.6 3.4 0.0  0.0 2.7 3.4 2.1 4.6  1.9 0.7 3.0 
Percentage of Energy                 
CHO (%) - 33.3 47.1 33.8 51.6 26.1  34.3 40.9 41.3 30.0 42.3  39.9 38.9 43.8 
PRO (%) - 28.3 12.8 28.3 29.8 26.2  38.6 24.3 12.7 30.8 27.5  32.7 35.7 16.5 
Fat (%) - 36.2 37.0 35.8 15.1 46.0  24.8 32.2 38.2 37.2 22.9  22.5 22.7 36.8 
Supplement Intake                 
PRO from Supplements (%) - 12.3 15.5 22.7 17.5 0.0  5.4 17.2 20.8 25.8 16.2  24.8 0.0 17.9 
Energy from Supplements (%) - 7.6 9.1 15.6 10.5 0.0  4.8 10.2 10.7 19.4 9.7  4.0 0.0 4.0 
CHO Carbohydrate, PRO Protein, BW bodyweight, - measurement not recorded 
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Figure 1. Competitive Strongmen’s Diet as a Percentage Food Group Intake. Others, includes food groups that made up less than 1 % of 
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Table 4. Performance metrics for Competitive Strongmen Over 24 Weeks 
 Baseline  12 weeks  24 weeks 
Participant no. 1 2 3 4 5 6  1 2 3 4 5  1 2 3 
Hand Grip Strength                 
Left (kgf) 59 74 65 46 51 37  60 75 62 53 56  59 76 62 
Right (kgf) 68 78 69 56 47 51  62 80 60 45 46  69 87 68 
Wingate                 
Peak Watts (W) 979 1971 1350 1733 1030 1158  1321 1904 1444 1387 1098  1363 1941 1389 
An. Power (W/kg BW) 6.9 11.0 9.6 12.3 10.2 8.9  9.6 11.0 10.5 10.3 10.8  9.5 11.4 10.4 
Mean Watts (W) 755 1209 1120 1175 869 910  738 1146 1230 1093 874  574 1227 1200 
An. Capacity (W/kg BW) 5.3 6.8 8.0 8.3 8.6 7.0  5.3 6.6 8.9 8.1 8.6  4.0 7.2 9.0 
Min Watts (W) 584 890 892 803 638 640  349 748 986 752 672  295 797 959 
Fatigue Index (%) 20.4 55.9 29.1 47.2 23.8 26.2  49.1 58.9 31.8 33.9 24.2  53.9 58.7 30.1 
Total Work (J) 15091 24176 22401 23494 17378 18205  14770 22910 24602 21860 16248  114475 24530 23996 
Abbreviations. kgf kilograms of force, An. anaerobic, W watts, J joules, % percentage 
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DISCUSSION 
 
To our knowledge, this is the first 
longitudinal observation to report health 
and performance outcomes in strongmen 
competitors. This study is also the first to 
document the energy intake of strongmen 
competitors. The aim of this report was to 
characterise metabolic and performance 
metrics of strongman so health 
professionals, coaches and dieticians 
might better understand these 
populations. Analysis of the data indicates 
that the metabolic health of the current 
cohort is similar to previous reports of 
similar populations (8,9). All the 
participants were classified as clinically 
obese, a number displayed symptoms of 
hypertension, and had elevated TC and had 
reduced HDL in some, but not all cases. 
Confectionary, savoury snacks, processed 
meats and sugar sweetened beverages 
accounted for over 20 % of the food items 
consumed; this dietary pattern 
contributed to a high saturated fat intake. 
Strongmen might therefore be encouraged 
to consume a diet higher in lean meats, 
and omega-3 fatty acid containing food 
items to more effectively manage their 
blood lipid levels. Although consideration 
is needed for the practicalities of making 
these changes where energy intake is high. 
Furthermore, strongmen may benefit from 
incorporating aerobic exercise into their 
training regimes in an attempt improve 
their blood pressure and lipid profile and 
reduce their risk of CVD.  
 
Anthropometrics and indirect calorimetry 
 
Participant’s weight, BMI and FM was 
between 101 to 179 kg, 33 to 48 kg/m2 and 
28 to 39 % respectively. This large mass is 
consistent with reports in strongmen 
populations, NFL offensive linesmen and 
sumo-wrestlers (7-9,23). To our 
knowledge, the 179 kg strongman is also 
likely one of the largest athletes ever 
reported in the scientific literature (24).  All 
strongmen were clinically obese (BMI > 
29.9 kg/m2), and two were morbidly obese 
(BMI > 40 kg/m2) significantly increasing 
their risk for CVD, breast, colon, prostate, 
endometrium, kidney and gall bladder 
cancer and T2DM (25). Furthermore, all 
participants had a WC greater than 104 cm 
(range 105 to 139 cm) and a WHR over 0.90 
(range 0.92 to 1.01). Both measures are 
indicative of visceral fat, and 
measurements greater than 104 cm, and 
0.90 are associated with an increase the 
risk for the aforementioned diseases (25). 
Blood pressure of participants and resting 
heart rate was also similar to offensive 
linesman and strongmen competitors 
(8,9). Optimal blood pressure is considered 
to be 120 / 80 mmHg in adults of this age, 
however three participants were noted as 
hypertensive at baseline based on the 
WHO cut offs for CVD risk (systolic blood 
pressure: 140 – 159, or diastolic blood 
pressure: 90 – 99) (26).  
 
Energy requirements and prediction 
equations were dependent on body mass 
as expected. Prediction equations however 
over or underestimate indirect calorimetry 
by as much as 53 to 64% in some cases. 
Reasons for this discrepancy may be two-
fold, although RMR is largely dependent on 
body mass, both FFM and FM are known to 
be independent predictors of BMR (27). As 
a result, prediction equations not 
accounting for both FFM and FM are less 
reliable when compared to indirect 
calorimetry measurements in obese 
population (28). To account for body 
composition the Cunningham (19) 
prediction equations were also used, 
however, they were no more effective at 
predicting RMR than the Schofield 
equations (18). Secondly, although 
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participants were fasted and rested on the 
morning of the trial, elevated CK levels 
reflect those seen 24 to 48 h post exercise 
following weight training (29). On four 
occasions participants had CK levels 
greater than 500 u/I indicative of 
strenuous prior exercise. The effect of 
prior exercise on RMR is well known and 
has been attributed to excess post-
exercise O2 consumption (EPOC). EPOC 
may be present up to 48 h post exercise 
and depending on the intensity of the prior 
exercise may increase by as much as 24.7 
% (30). It is worth noting however the 
practical difficulties in recruiting athletes 
during a competitive season, and that 
these athletes basal state is likely reflective 





With the exception of participant 3 and 4, 
all participants had a TC and LDL less than 
the 6.1 mM and 4.0 mM cut offs for 
increased CVD risk (26). Among adults in 
the UK a TC values over 5 mM is consider 
high and optimal under 4.0 mM (31). 
Interestingly participant 2 reported a TC of 
9.9 mM at baseline, before reducing his TC 
to less than 6.0 by the third laboratory visit. 
This drop in TC coincided with a reduction 
in the saturated fat content of his and an 8 
kg drop in bodyweight which was 
accompanied by  a reduction in FM, as he 
actively attempted to improve his blood 
lipid profile. Furthermore, he also ceased 
taking AAS, which are known to negatively 
influence blood lipids (17).  In 
consideration, of the overall lipid profile of 
our strongmen the values are similar to 
those reported in Strongman and NFL 
populations (8,9) LDL and TAG 
concentrations less than 2.0 mM is 
considered to be healthy in people at risk 
of heart disease, while a HDL of 1.0 mmol/l 
is considered ideal (32). Unfortunately, 
because of a technical error HDL and LDL 
levels were unavailable for all time points, 
however in five instances HDL levels were 
less than 1.0 mM, LDL was less than 2.0 
mM and TAG ranged between 0.8 and 2.2 
mM.  Blood lipids from strongmen have 
previously been compared to marathon 
runners and healthy controls, and the 
profiles reported here reflect the previous 
observations of elevated TC and reduced 
HDL (9). Of most concern are the HDL 
levels, the effect that AAS have on HDL is 
well known this may account for the lower 
than 1.0 mM values reported here, 
furthermore the high saturated fat diet 
may have been a contributing factor (33). 
Moreover Venckunas (9), reported 
impaired myocardial relaxation in 
strongmen, consistent with AAS use (16).  
All participants reported FBG levels of less 
than 5.8 mM. FBG levels are an indicator of 
T2DM risk and WHO classifies prediabetes 
as levels between 6.1 to 6.9 mM (34). 
Obesity significantly increases an 
individual’s risk of impaired glucose 
tolerance, it’s possible that the large 
amount of LBM strongmen possess 
provides some protection against T2DM 
(35). The LBM of the participants was 
between 72 to 109 kg, well beyond the 
61.7 kg reported for a reference man (36), 
which might explain some of the 
discrepancies between the 
anthropometrics and biochemical 
markers. Similar findings were observed in 
the offensive linesman where participants 
had a high BMI but normal FBG levels (8). 
Salivary CRP values were within reference 
ranges for a healthy population, while 
testosterone concentrations were 
elevated above normal healthy adults 
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Power output and hand grip strength 
 
In consideration of power output and body 
mass versus LBM we observe that the 
person with the greatest body mass also 
has the greatest power output (see fig 3) 
and the greatest lean tissue value. It is not 
possible with this data to determine a strict 
relationship between lean tissue and 
power output, or overall body mass and 
power output. It is also worth pointing out 
that strongmen events are not all static 
movements (e.g. pushing a barbell from 
the chest) but often involve pulling and 
pushing weight over distance (pulling a 
bus) and overall bodyweight as well as lean 
tissue almost certainly play a part in the 
dynamics of moving large objects. The 
Wingate test however does make it easy to 
make comparisons with other sports and 
peak wattages (979 to1971 w) were 
greater than values reported amongst elite 
athletes from different sports (mean 833 
w), NCAA Division 1 Power athletes (mean 
1084 w), and collegiate line backers (mean 
1223) (38-40). Scaled for body mass 
strongmen however were less powerful 
than track and field athletes (10.2 w/kg BW 
vs 12.2 w/kg BW) (41), although the ability 
to generate a greater absolute peak power 
is a more relevant metric for this 
population since strongman is not a weight 
class sport. HGS is known to correlate with 
upper body strength, ballistic performance 
and powerlifting strength (42). The values 
reported here are the first-time strongman 




A key concern amongst strongmen is 
gaining and maintaining a large body mass, 
so overall energy intake needs to be high. 
Therefore, consideration of the 
macronutrient breakdown and especially 
the quality of fatty acids in the diet is 
warranted; overall the intake of fat was 
34.37 % and average energy intake over 
5000 kcals. All athletes met the ACSM 
guidelines for protein intake (1.6 to 2.0 
g/kg BW) and were in an energy surplus, 
however they may benefit from consuming 
a diet slightly higher in carbohydrate to 
meet the 4.0 to 7.0 g/kg BW 
recommendations for strength athletes 
(43). A key question for this group is, what 
would the effects of achieving their energy 
requirements if fat was reduced or sources 
were switched from red meat, 
confectionary and high saturated fat foods 
to sources such as avocado, nuts and fatty 
fish i.e. essentially those with a lipid profile 
higher in mono and polyunsaturated fatty 
acids which is considered healthier and 
potentially cardio-protective (44-47). 
Alongside the consideration of fatty acid 
intake dieting for AAS use needs to be 
considered as evidence suggests a negative 
disruption to lipid profiles (33). In the 
present case-study lipid profiles are the 
metric which denotes a health risk in this 
group- and anecdotally we note that in 
participant 2 reducing TC to half the 
original level after he made changes to 
dietary intake following nutritional advice 





Prediction equations proved to be 
unreliable for estimating energy 
requirements in this population, however 
the energy intake of participants suggests 
they were likely meeting daily energy 
requirements. Measurement of health 
indices related to cardiovascular health 
suggest an elevated risk of CVD in this 
population, although the large amount of 
LBM they possess may offers some 
protection against T2DM. Continuous 
monitoring of competitors in relation to 
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body composition, body mass, blood 
pressure and lipid profiles is warranted and 
will be especially informative when 
athletes are using higher energy density 
'healthier' foods, or where athletes are 
using AAS. The evidence around altering 
saturated fat intake in the diet needs 
considering- for example: simply reducing 
saturated fat intake and replacing this with 
refined carbohydrate does not improve 
indices of cardiovascular health; whereas 
exchanging saturated fats with high fibre 
whole grains and unsaturated fats seem to 
positively effect cardiovascular risk factors 
(45).  Examples of ‘healthier food’ 
alternatives include peanut butter, nuts 
and seeds in general, avocado, salmon- 
essentially foods high in protein and 
unsaturated fats compared with the 
saturated and trans fats obtained from fast 
food, chocolate, cookies etc. Finally, 
strongmen may wish to consider adding 
more cardiovascular training to their 
regime to further improve blood lipid 
profiles and aerobic fitness in concurrence 
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SUPPLEMENTARY DATA 
Supplement S1. Participant 3 Baseline Sample Strongman Menu 
Item/description Amount (g) Item/description Amount (g) 
Meal 1  Meal 5  
Nestle, Cheerios 80 g English Cheddar Cheese 45 g (1 x average portion) 
Whole Milk Cows 515 ml (1 pint) Stilton Blue Cheese 35 g (1 x average portion) 
Brown Bread, toasted 64 g (2 x medium slices) Brie Soft Cheese 40 g (1 x average portion) 
Seedless Grapes 250 g (Half a punnet) Low Fat Yogurt 125 ml (1 x average pot) 
Low Fat Yoghurt 250 g (2 x average pots)    
Banana & Strawberry Smoothie (with whole 
milk) 
400 g (1 large portion)   
Meal 2 – Pre Exercise  Meal 6  
Preworkout (Brand: PhD) 15 g (1 serving) Spaghetti Bolognese  
Maltodextrin 60 g White Pasta 400 g (extra-large portion) 
BCAA Powder 15 g (1 tablespoon) Minced Beef 300 g (extra-large portion) 
Coca-Cola 500 ml (1 bottle) Tomato Passata 200 ml (half a jar) 
Meal 3 – Post Exercise  Garlic Bread 240 g (1 baguette) 
Whey Protein (Brand: NRG) 30 g (one serving) Meal 7  
Whole Milk 250 ml (half pint) Walkers, Ready Salted 
Crisps 
90 g (2 x packet) 
Banana 200g (2 x average banana) McVities, Mini Cheddars 50 g (1 x packet) 
Cadburys Twirl 160 g (4 x small bars) Cadburys Twirl 160 g (4 x small bars) 
Meal 4  Haribo, Super Mix 215 g (1 large packet) 
McVities, Mini Cheddars 50 g (1 x packet)   
Walkers, Ready Salted Crisps 90 g (2 x packet)   
Egg Mayonnaise Sandwich White Bread 290g (2 x sandwich)   
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Supplement S2a-c. Anaerobic Power Output Assessed by Wingate Relative to the Lean Body Mass of 
Strongmen. A baseline, B 12 weeks, C 24 weeks, Solid line ( ̶    ) indicates power output (W), broken line (- - -) 
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